Mode of action of hypoglycemic agents. I. Inhibition of gluconeogenesis by quinaldic acid and 5-methoxyindole-2-carboxylic acid.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002247:Carbon Isotopes; D003864:Depression, Chemical; D004032:Diet; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005632:Fructose / Q000378:metabolism; D005943:Gluconeogenesis / Q000187:drug effects*; D005994:Glycerophosphates / Q000378:metabolism; D006003:Glycogen / Q000097:blood; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007657:Ketone Bodies / Q000097:blood; D007668:Kidney / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D008930:Mitochondria, Liver / Q000378:metabolism*; D010477:Perfusion; D011773:Pyruvates / Q000378:metabolism; D011804:Quinolines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D001786:Blood Glucose; D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D005994:Glycerophosphates; D007004:Hypoglycemic Agents; D007211:Indoles; D007657:Ketone Bodies; D007773:Lactates; D008112:Liver Glycogen; D011773:Pyruvates; D011804:Quinolines; D005632:Fructose; D006003:Glycogen